| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 96 |
| 1 | HYDRALAZINE HYDROCHLORIDE | 93 |
| 2 | TACROLIMUS | 75 |
| 3 | RITUXIMAB | 71 |
| 4 | AMLODIPINE | 70 |
| 5 | METHOTREXATE SODIUM | 69 |
| 6 | MYCOPHENOLATE MOFETIL | 67 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 67 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 67 |
| 9 | TACROLIMUS OINTMENT 0.1% | 67 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDRALAZINE HYDROCHLORIDE | 93 | 0.0348 |
| 1 | ACETAMINOPHEN CHLORPHENIRAMINE MALEATE PHENYLEPHERINE HYDROCHLORIDE | 1 | 0.0233 |
| 2 | ADALIMUMAB-AQVH | 1 | 0.0101 |
| 3 | PROPYLTHIOURACIL | 11 | 0.0053 |
| 4 | PENICILLAMINE | 4 | 0.0043 |
| 5 | CHLORZOXAZONE | 5 | 0.0038 |
| 6 | IDARUCIZUMAB | 4 | 0.0028 |
| 7 | CLEVIDIPINE | 1 | 0.0027 |
| 8 | ESTRADIOL AND NORETHINDRONE ACETATE | 1 | 0.0026 |
| 9 | CARBAMIDE PEROXIDE | 1 | 0.0023 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Humanized Monoclonal Antibody Fragment [EPC] | 4 | 0.0028 |
| 2 | Complement 5a Receptor Antagonist [EPC] | 12 | 0.0018 |
| 3 | Hematopoietic Stem Cell Mobilizer [EPC] | 2 | 0.0013 |
| 4 | Thyroid Hormone Synthesis Inhibitor [EPC] | 13 | 0.0013 |
| 5 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 74 | 0.0008 |
| 7 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 8 | Antimalarial [EPC] | 7 | 0.0007 |
| 9 | Antiprotozoal [EPC] | 7 | 0.0007 |